AVIR
Atea Pharmaceuticals, Inc.
+0.15 (+2.91%)5.30USD83.0K成交股數425M市值–本益比(近四季)1.2股價營收比–營收年增(近四季)2026-11-11下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | – | – | – | – | – | – | – | – | – | – | – | – |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | 28.2M | 41.1M | 47.8M | 38.3M | 32.3M | 29.6M | 26.2M | 34.7M | 57.6M | 35.0M | 28.2M | 22.1M |
| 銷售管理費用 | 6.9M | 6.9M | 7.1M | 7.2M | 9.1M | 9.5M | 11.0M | 12.2M | 12.2M | 11.5M | 12.6M | 13.2M |
| 營業利益 | −35.1M-15% | −48.0M+23% | −54.9M+48% | −45.6M-3% | −41.3M-41% | −39.0M-16% | −37.2M-9% | −46.9M+33% | −69.8M | −46.6M | −40.8M | −35.2M |
| 營業利益率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 稅後淨利 | −32.9M-11% | −45.4M+33% | −44.5M+43% | −42.0M+4% | −37.2M-41% | −34.3M-13% | −31.2M-6% | −40.5M+44% | −63.2M | −39.2M | −33.1M | −28.2M |
| 淨利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 稀釋 EPS | -0.41-7% | -0.57+42% | -0.57+54% | -0.53+10% | -0.44-41% | -0.40-13% | -0.37-8% | -0.48+41% | -0.75 | -0.46 | -0.40 | -0.34 |
| 稀釋股數 | 80.1M | 79.2M | 81.5M | 79.1M | 83.7M | 85.2M | 84.4M | 84.3M | 83.9M | 83.4M | 83.4M | 83.4M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 76.5M | 79.3M | 95.7M | 77.3M | 87.7M | 119M | 98.5M | 243M | 161M | 144M | 138M | 214M |
| 應收帳款 | – | – | – | – | – | – | – | – | – | – | – | – |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 232M | 267M | 315M | 343M | 392M | 440M | 491M | 510M | 553M | 595M | 608M | 626M |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | – | – | 39.8M | 27.2M | 27.2M | 28.9M | 32.4M | 33.9M | 48.7M | 39.8M | 26.3M | 23.7M |
| 股東權益 | 204M | 234M | 275M | 316M | 364M | 411M | 459M | 476M | 504M | 555M | 582M | 602M |
| 負債比 | – | – | 12.6% | 7.9% | 6.9% | 6.6% | 6.6% | 6.6% | 8.8% | 6.7% | 4.3% | 3.8% |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −46.4M+52% | – | – | – | −30.6M | – | – | −39.9M | – | – | – |
| 資本支出 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流 | – | – | – | – | – | – | – | – | – | – | – | – |
| 折舊攤銷 | – | 104K | – | – | – | 104K | – | – | 104K | – | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | – | – | – | – | – | – | – | – |
營收拆解
這家公司的 XBRL 沒有標分部、產品或地區營收。多半是單一業務,或只在 10-K 文字裡揭露。
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | – | – | −158M | –% | -1.94 | – |
| FY2024 | – | – | −168M | –% | -2.00 | – |
| FY2023 | – | – | −136M | –% | -1.63 | – |
| FY2022 | – | – | −116M | –% | -1.39 | −123M |
| FY2021 | 351M | +622.5% | 121M | 34.4% | 1.37 | −87.0M |
| FY2020 | 48.6M | – | −10.9M | -22.5% | -0.51 | 297M |
| FY2019 | – | – | −14.0M | –% | -1.39 | −12.8M |
| FY2018 | – | – | −9.1M | –% | -0.90 | −7.9M |